sulfinpyrazone has been researched along with Aortic Valve Stenosis in 3 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Aortic Valve Stenosis: A pathological constriction that can occur above (supravalvular stenosis), below (subvalvular stenosis), or at the AORTIC VALVE. It is characterized by restricted outflow from the LEFT VENTRICLE into the AORTA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steele, P | 1 |
| Weily, H | 1 |
| Davies, H | 2 |
| Ppppas, G | 1 |
| Genton, E | 2 |
| Woodruff, RK | 1 |
| Goble, AJ | 1 |
| Steele, PP | 1 |
| Weily, HS | 1 |
3 other studies available for sulfinpyrazone and Aortic Valve Stenosis
| Article | Year |
|---|---|
Platelet survival time following aortic valve replacement.
Topics: Adult; Aortic Valve; Aortic Valve Insufficiency; Aortic Valve Stenosis; Aspirin; Blood Platelets; Ce | 1975 |
Control of cardiac valve related hemolytic anemia by sulphinpyrazone.
Topics: Anemia, Hemolytic; Aortic Valve Stenosis; Heart Valve Prosthesis; Humans; Male; Middle Aged; Sulfinp | 1985 |
Platelet survival in patients with rheumatic heart disease.
Topics: Adenosine Diphosphate; Aortic Valve Stenosis; Blood Platelets; Cell Survival; Chromium Radioisotopes | 1974 |